Poster Abstract Session:
126. Hepatitis
Friday, October 19, 2012: 12:30 PM-2:00 PM
Room: SDCC Poster Hall F-H

Topical Category: C. Clinical Studies and V. Clinical Virology

Tracks: Adult ID, Pediatric ID

Presentations:

Responsiveness of Interferon Therapy Pediatric Age Group with Chronic Hepatitis B Infection
Kai Lin, MD MS ; Tianjiao Yang, MD ; Yi Lu, MD ; Yanfeng Zhu, MD ; Xinbao Xie ; Xiaohong Wang, MD ; Qirong Zhu, MD ; Ting Zhang, MD PhD ; Hui Yu, MD PhD

Staging HCV Disease in the Chronic Hepatitis Cohort Study (CHeCS)
Scott Holmberg, MD, MPH ; Mei Lu, PhD ; Lora Rupp, MSE, MBA ; Anne Moorman, BSN, MPH ; Stuart C. Gordon, MD

Community Knowledge and Attitudes Regarding HCV Disease, Testing, and Treatment Among a High-risk Urban Population
Brianna L. Norton, DO ; Sarah H. Timberlake ; Emily J. Hecker, RN, MSN ; Neela D. Goswami, MD ; Kim M. Huffman, MD, PhD ; Anneka M. Landgraf ; Corrine I. Voils, PhD ; Susanna Naggie, MD ; Jason Stout, MD, MHS, FIDSA

Insulin resistance is the most important factor in virological relapse by chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirin
Eiichi Ogawa, MD., PhD. ; Norihiro Furusyo, MD., PhD. ; Masayuki Murata, MD., PhD. ; Hiroaki Ikezaki, MD. ; Takeshi Ihara, MD. ; Takeo Hayashi, MD. ; Kazuhiro Toyoda, MD. ; Kyoko Okada, MD., PhD. ; Mosaburo Kainuma, MD., PhD. ; Jun Hayashi, MD., PhD.

The Changing Epidemiology and Patient Characteristics of Hepatitis Delta Virus Infection in South London, United Kingdom
CY William Tong, MD ; Radha Asher, MRCP ; Ranjababu Kulasegaram, FRCP ; Mark Wilkinson, MD ; Terry Wong, MD
Posters
  • IDWeek poster HDV WT v1.4.jpg (906.6 kB)

  • Incidence of and Risk Factors for Reactivation of Hepatitis B in a Cohort of Alaska Native Persons in the Inactive Phase of Chronic Hepatitis B
    Rania A. Tohme, MD, MPH ; Lisa Bulkow, MS ; Chriss Homan, BS ; Susan Negus, RN ; Brenna Simons ; Brian McMahon, MD
    Posters
  • Tohme_IDSA 2012 poster.pdf (377.0 kB)

  • Age is the most important risk of hepatocellular carcinoma after sustained virological responders to antiviral treatment for chronic hepatitis C
    Norihiro Furusyo, MD., PhD. ; Eiichi Ogawa, MD., PhD. ; Masayuki Murata, MD., PhD. ; Jun Hayashi, MD., PhD.

    Hepatitis A Virus Infection in Food Handlers in the United States, 1993-2011
    Karine Kentenyants, MD, MPH ; Umid M. Sharapov, MD, MSc ; Justina Groeger, MPH ; Scott Holmberg, MD, MPH

    Missed Opportunities in the Management of Chronic Hepatitis B
    Misha Huang, MD ; William Burman, MD ; Kirsten Wall, MHS ; Robert Beum, CCP
    Posters
  • Hep B poster-36x56_final.pdf (454.2 kB)

  • Chronic Viral Hepatitis B and C
    Nanuli Ninashvili, MD., PH.D ; Irakli Mchedlishvili

    Hospitalizations and Deaths among Acute Hepatitis B and C Cases Reported from U.S Enhanced Surveillance Sites, 2006-2010
    Kashif Iqbal, MPH ; Monina Klevens, DDS, MPH ; Jennifer Baumgartner ; Elena M. Rizzo, MA ; Sue Speers ; Kristin Sweet ; Ann Thomas, MD, MPH ; Candace W Vonderwahl, BS

    Personalized Learning: A Novel Educational Model to Bridge Clinical Practice Gaps in Chronic HBV Infection
    Nancy Reau, MD ; Susan Smith, MN, PhD ; Wendy Cerenzia, MS ; Simi Hurst, PhD
    Posters
  • HBV-PL-poster_Final.pdf (842.8 kB)

  • Assessment of Clinician Practices in Screening and Linkage to Care for Chronic Hepatitis B
    Melissa Osborn, MD ; Yelena Lyustikman, MS ; Wendy Cerenzia, MS ; Jennifer J Brown, PhD ; Simi Hurst, PhD

    Treating HIV/HCV Co-infection: Experiences from an Inner City Clinic
    Paula Dilanchian, DO ; Khaled Deeb, PhD, MBA ; Kanwal Razzaq, MD ; Dushyantha Jayaweera, MD, MRCOG, FACP

    CME Credits:


    Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 17th with the exception of research findings presented at the IDWeek press conferences.